NANOSTRUCTURED DELIVERY SYSTEM ANTI-DRUGS
A very promising approach to increase the selectivity of antitumor action and overcome the systemic toxicity of the active substances is the use of nanoscale SDD. In recent years, have become increasingly popular drug development in the form of liposomal and micellar colloidal systems, many of which are US-successfully used in clinical practice. We review the characteristics of liposomal and micellar carriers of anticancer drugs, is a mechanism of selective accumulation SDD in pathological foci.